INNO-LiPA® HCV 2.0 Genotyping
Accurately identifies HCV genotypes and key subtypes for personalized treatment. Validated on serum and plasma, compatible with TENDIGO™ automation and LIRAS© software.
Product Overview
INNO-LiPA® HCV 2.0 Genotyping analyses variations in the 5’ untranslated region (5’ UTR) and core region. This provides a more accurate distinction between the subtypes 1a, 1b and 6 (c-l). The INNO-LiPA HCV 2.0 Genotyping identifies HCV genotypes 1 – 6 and 15 subtypes for optimal and personalised patient therapy.
- Compatible with common extraction platforms
- Simultaneous amplification of HCV 5′ UTR and core region for detection of genotype 1-6 and accurate distinction between subtype 1a, 1b, 6 (c-l)
- Test can be performed manually or automated
- LiRAS software for fast and objective interpretation.
- LIMS connectivity
INNO-LiPA® HCV 2.0 Genotyping provides accurate identification of HCV genotypes and key subtypes like 1a and 1b – essential for personalised treatment. With validated use on serum and plasma, and automation via TENDIGO™ and LIRAS© software, it simplifies complex genotyping with reliable, fast results and minimal hands-on time.
INNO-LiPA HCV 2.0 Genotyping workflow
Step 1
RNA extraction - RNA extraction flexibility - compatible with common extraction platforms
Step 2
Amplification - Easy to use one-step PCR master mix - simultaneous amplification of HCV 5' UTR and core region for detection of genotype 1-6 and accurate distinction between subtype 1a, 1b, 6 (c-I)
Step 3
Hybridisation on strips - Reverse hybridization, a robust technology, uses 22 specific probes
Step 4
Interpretation - Reliable interpretation option - Manual interpretation, LiRAS for LiPA HCV v4, LiRAS allows a fast and objective reading, to ensure accurate interpretation. Saves electronic image of each strip. Connection to LIMS.
